BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26234533)

  • 1. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
    Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
    Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype.
    Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y
    Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys.
    Tsukada H; Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2127-36. PubMed ID: 24919653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.
    Tsukada H; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):755-63. PubMed ID: 24258008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.
    Terada T; Therriault J; Kang MSP; Savard M; Pascoal TA; Lussier F; Tissot C; Wang YT; Benedet A; Matsudaira T; Bunai T; Obi T; Tsukada H; Ouchi Y; Rosa-Neto P
    Mol Neurodegener; 2021 Apr; 16(1):28. PubMed ID: 33902654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
    Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
    J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ¹⁸F-BCPP-EF as a PET probe for complex I activity in the brain.
    Tsukada H
    Methods Enzymol; 2014; 547():417-31. PubMed ID: 25416368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [
    Coughlin JM; Du Y; Rosenthal HB; Slania S; Min Koo S; Park A; Solomon G; Vranesic M; Antonsdottir I; Speck CL; Rootes-Murdy K; Lerner A; Rowe SP; Wang Y; Lesniak WG; Minn I; Bakker A; Smith GS; Dannals RF; Kuwabara H; Horti A; Wong DF; Pomper MG
    Neuroimage; 2018 Jan; 165():118-124. PubMed ID: 28993233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
    J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
    Harada N; Nishiyama S; Kanazawa M; Tsukada H
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys.
    Tsukada H; Kanazawa M; Ohba H; Nishiyama S; Harada N; Kakiuchi T
    J Nucl Med; 2016 Jun; 57(6):950-3. PubMed ID: 26912430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
    Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
    JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
    Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
    Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH; Manook A; Grimmer T; Arzberger T; von Reutern B; Henriksen G; Drzezga A; Förster S; Schwaiger M; Wester HJ
    ACS Chem Neurosci; 2015 Mar; 6(3):428-37. PubMed ID: 25482310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.
    Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A
    Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.